Resapp Health

Resapp Health Net Income

The Net Income of Resapp Health (RAP.AX) as of Oct 20, 2026 is -1.89 M AUD. In the previous year, Net Income was -2.49 M AUD — a change of -23.84% (higher).

Net Income

-1.89 MAUD

YoY

-23.84%

Last updated:

In 2024, Resapp Health's profit amounted to -1.89 M AUD, a -23.84% increase from the -2.49 M AUD profit recorded in the previous year.

The Resapp Health Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Income
Date
Net Income
Jan 1, 2018
-6.53 M AUD
Jan 1, 2019
-5.44 M AUD
Jan 1, 2020
-8.47 M AUD
Jan 1, 2021
-6.77 M AUD
Jan 1, 2022
-7.10 M AUD
Jan 1, 2023
-2.49 M AUD
Jan 1, 2024
-1.89 M AUD
Jan 1, 2025 (e)
0.00 AUD
The Resapp Health Net Income history
YEARNet IncomeYoY
est0.00AUD-100.00%
-1.89 MAUD-23.84%
-2.49 MAUD-64.97%
-7.10 MAUD+4.75%
-6.77 MAUD-20.01%
-8.47 MAUD+55.71%
-5.44 MAUD-16.75%
-6.53 MAUD-34.88%
-10.03 MAUD+212.75%
-3.21 MAUD+556.03%
-489,000.00AUD-15.40%
-578,000.00AUD-37.37%
-922,808.00AUD+10.91%
-832,000.00AUD+57.87%
-527,000.00AUD-335.14%
224,122.00AUD-118.74%
-1.20 MAUD-66.70%
-3.59 MAUD-2.18%
-3.67 MAUD+102.20%
-1.82 MAUD+157.22%
-706,000.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Resapp Health Revenue

Resapp Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
0.00 AUD
-7.62 M AUD
-6.53 M AUD
Jan 1, 2019
0.00 AUD
-8.27 M AUD
-5.44 M AUD
Jan 1, 2020
0.00 AUD
-9.63 M AUD
-8.47 M AUD
Jan 1, 2021
69,731.00 AUD
-8.11 M AUD
-6.77 M AUD
Jan 1, 2022
2.51 M AUD
-6.94 M AUD
-7.10 M AUD
Jan 1, 2023
0.00 AUD
-2.50 M AUD
-2.49 M AUD
Jan 1, 2024
0.00 AUD
-1.97 M AUD
-1.89 M AUD
Jan 1, 2025 (e)
85.15 M AUD
0.00 AUD
0.00 AUD

Resapp Health Margins

Resapp Health stock margins

The Resapp Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Resapp Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Resapp Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
100.00 %
- %
- %
Jan 1, 2019
100.00 %
- %
- %
Jan 1, 2020
100.00 %
- %
- %
Jan 1, 2021
100.00 %
-11,628.98 %
-9,714.47 %
Jan 1, 2022
100.00 %
-276.39 %
-282.48 %
Jan 1, 2023
100.00 %
- %
- %
Jan 1, 2024
100.00 %
- %
- %
Jan 1, 2025 (e)
100.00 %
0.00 %
0.00 %

Resapp Health Stock analysis

What does Resapp Health do? ResApp Health Ltd is an Australian company that focuses on the development of digital diagnostic and treatment solutions in the field of respiratory diseases. The company was founded in 2014 by Tony Keating and Philippa Lewis, both of whom have significant experience in the medical technology industry. The company aims to improve and simplify the diagnosis of respiratory diseases by developing a diagnosis based on cough and breath sounds. To achieve this, the company has developed an intelligent system based on machine learning and artificial intelligence that analyzes individual sound waves and provides an accurate diagnostic capability. ResApp Health's business model is based on the development of digital diagnostic and treatment solutions in the field of respiratory diseases, which are offered through various distribution channels. The company offers both mobile apps and clinical diagnostic systems. ResApp Health operates in various divisions at different levels. On the one hand, the company conducts research and development to continuously improve its products. On the other hand, it works closely with clinicians, scientists, and other industry experts to enable the best possible patient treatment. Products offered by ResApp Health include digital diagnostic systems in the field of respiratory diseases that function based on cough and breath sounds. The products are offered for use in both clinical practice and at home to enable fast and accurate diagnosis. Another important area in which ResApp Health operates is the treatment of respiratory diseases. The company offers digital therapy platforms tailored to the individual needs of patients, enabling improved therapy. ResApp Health has already achieved a number of important milestones. For example, in 2016, the company received CE marking for its digital diagnostic system, and in 2017, it completed a clinical study that demonstrated the system's high accuracy in diagnosing respiratory diseases. Overall, ResApp Health has great potential to play an important role in the field of diagnosis and treatment of respiratory diseases in the future. With a strong focus on research and development and close collaboration with industry experts, the company will continue to offer innovative solutions to improve patient health. Resapp Health is one of the most popular companies on Eulerpool.

Net Income Details

Understanding Resapp Health's Profit Margins

The profit margins of Resapp Health represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Resapp Health's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Resapp Health's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Resapp Health's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Resapp Health’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Resapp Health stock

Net Income of Resapp Health is -1.89 M AUD in 2024.

Net Income of Resapp Health changed from -2.49 M AUD to -1.89 M AUD, representing a -23.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Income Resapp Health since 2006 – with annual values, charts, and detailed analysis.

The achievement of a profit is the biggest goal of a company. The profit can be used for distribution or reinvestment. The profit (also called annual surplus or EAT, earnings after taxes) is the positive difference between income and expenses in a period as shown in the income statement. A negative annual surplus is called annual loss. Both performance measures are also combined under the neutral term annual result.

The Net Income is derived from all revenues / sales minus the expenses in the period under review. The following overview clearly shows which positions contribute to the annual surplus and where the differences lie compared to other variants of profit such as EBT, EBIT, and EBITDA.

Net Income's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Income's Resapp Health historically and in real time.

The profit in evaluating a stock

History, usage, calculation, and application of earnings in securities trading.

The history of earnings dates back to the beginnings of modern business organization. Since the beginning of industrialization, companies have been established to generate profits, and profits have been considered an essential part of corporate management. In recent years, the importance of earnings for investors has continued to rise, as many investors seek to find stocks that generate solid earnings.

Use of Profits

In securities trading, profits are used to determine the value of a stock. A company that generates profits is considered financially healthy and its stocks are valued higher, while a company that does not generate profits is considered less reliable and therefore receives a lower valuation. Investors can review the profits of each company by examining the relevant documents such as the income statement, the annual financial statements, and the income tax audits.

Calculation of profits

There are several different ways to calculate profits. The simplest way to calculate profits is by calculating net earnings. Net earnings are calculated by subtracting the company's expenses from its revenue. Another way to calculate profits is by calculating operating income. Operating income is calculated by subtracting the company's materials costs and employee wages and salaries from its revenue.

Use of profits

There are many different ways in which investors can use profits when evaluating stocks. One example is calculating the price-to-earnings ratio (P/E ratio). The P/E ratio is the relationship between the price of a stock and the company's earnings. When calculating the P/E ratio, the stock price is divided by the company's earnings. A low P/E value indicates that the stock has a good price-performance ratio, and a high P/E value indicates that the stock has a poor price-performance ratio.

Advantages and disadvantages of using profits

There are many advantages to using earnings in securities trading. Firstly, investors can check the financial health of a company by analyzing earnings. Secondly, investors can make a better decision about the valuation of a stock by calculating the P/E ratio. Thirdly, investors can reduce their risk by choosing stocks with a low P/E ratio.

However, there are also some drawbacks to relying on profits. Firstly, profits can be distorted if a company increases its profits through cost-cutting measures. Secondly, profits can present an inaccurate picture of a company's financial health if they are not calculated correctly. Thirdly, profits may not always be a reliable indicator of a company's future, as they can easily fluctuate.

t('components_kpi_Explanation_34')

Overall, it can be said that profits in securities trading are an important indicator of a company's financial health. Investors can analyze profits to get a better understanding of the company's financial health and make informed decisions about stock valuation. However, there are some disadvantages to using profits as they can sometimes be distorted or inaccurate. Therefore, it is important for investors to be cautious and carefully analyze profits before making a decision to buy or sell stocks.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Resapp Health

All Key Metrics — Resapp Health